Hypermethylation and inactivity of hepatitis C virus cDNA transgene in transgenic mice
Kato, T.; Ahmed, M.; Esumi, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 95-99
1995
ISSN/ISBN: 0047-1852 PMID: 7563908 Document Number: 453826
Document emailed within 1 workday
Related Documents
Choo, K.B.; Liew, L.N.; Liew, S.J.; Cheng, W.T. 1993: Hypermethylation of the human papillomavirus transgenome in transgenic mice Proceedings of the National Science Council Republic of China. Part B Life Sciences 17(4): 159-163DeWille, J.W.; Farmer, S.J. 1994: Structural analysis of the ras transgene in MMTV/v-Ha-ras transgenic mice Laboratory animal science 44(2): 131-134
Caner, M.üg.; Arat, S.; Bircan, R. 2008: Development of a hepatitis B virus carrier transgenic mice model Mikrobiyoloji Bulteni 42(1): 71-81
Shvemberger, I.N.; Ermilov, A.N.; Kapitskaia, M.Z.; Dvorianchikov, G.A.; Medvedeva, N.D.; Ginkul, L.B.; Tomilin, N.V. 1990: The production and characteristics of transgenic mice expressing the surface protein gene of the human hepatitis B virus Tsitologiia 32(3): 252-255
Vogel, J.; Hinrichs, S.H.; Napolitano, L.A.; Ngo, L.; Jay, G. 1991: Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene Cancer Research 51(24): 6686-6690
Smith, A.L.; Bottomly, K.; Winograd, D.F. 1987: Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus Journal of Immunology 138(10): 3426-3430
Rivella, S.; Sadelain, M. 1998: Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing Seminars in Hematology 35(2): 112-125
Ohuchi, K.; Matsuda, A.; Maeda, S.; Shimada, K.; Miyakawa, T. 1991: A transgenic mouse line developed to express human amyloidogenic transthyretin cDNA in the brain Biochemistry International 23(5): 809-817
Omer, C.A.; Chen, Z.; Diehl, R.E.; Conner, M.W.; Chen, H.Y.; Trumbauer, M.E.; Gopal-Truter, S.; Seeburger, G.; Bhimnathwala, H.; Abrams, M.T.; Davide, J.P.; Ellis, M.S.; Gibbs, J.B.; Greenberg, I.; Koblan, K.S.; Kral, A.M.; Liu, D.; Lobell, R.B.; Miller, P.J.; Mosser, S.D.; O'Neill, T.J.; Rands, E.; Schaber, M.D.; Senderak, E.T.; Oliff, A.; Kohl, N.E. 2000: Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor Cancer Research 60(10): 2680-2688
Picarella, D.E.; Kratz, A.; Li, C.B.; Ruddle, N.H.; Flavell, R.A. 1993: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice Journal of Immunology 150(9): 4136-4150
Ju, R.; Tian, Y.; Shen, Q.; Liu, C.; Mang, K. 1994: Cloning of polygalacturonase (PG) cDNA and inhibition effects of its antisense RNA on the expression of PG gene in transgenic tomato plants Chinese Journal of Biotechnology 10(2): 67-74
Sun, W.Y.; Coleman, M.J.; Witte, D.P.; Degen, S.J.F. 2002: Rescue of prothrombin-deficiency by transgene expression in mice Thrombosis and Haemostasis 88(6): 984-991
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Sutcliffe, S.; Taha, T.E.; Kumwenda, N.I.; Taylor, E.; Liomba, G.N. 2002: HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi Journal of Acquired Immune Deficiency Syndromes 31(1): 90-97
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Bérard, J.; Gaboury, L.; Landers, M.; De Repentigny, Y.; Houle, B.; Kothary, R.; Bradley, W.E. 1994: Hyperplasia and tumours in lung, breast and other tissues in mice carrying a RAR beta 4-like transgene EMBO Journal 13(23): 5570-5580